OR WAIT null SECS
© 2021 MJH Life Sciences and BioPharm International. All rights reserved.
© 2021 MJH Life Sciences™ and BioPharm International. All rights reserved.
March 02, 2021
In a pandemic, genetic vaccines offer several advantages over traditional approaches.
Despite the persistence of the patent thicket, and slow uptake by the medical community, biosimilars are positioned for growth in the US.
Overcoming time and cost constraints can help enable seed train intensification efforts to maximize product yield.
The need for real-time monitoring and control has spurred the development of new analytical tools.
March 01, 2021
Homology Medicines discusses how the clinical-stage biopharmaceutical company met its need for supply of adeno-associated virus vectors.
While manufacturing increases have been implemented for vials and syringes, meeting future market needs remains unpredictable.
Accelerated drug development timelines must accommodate all crucial elements of nonclinical safety studies.
Reviews of FDA initiatives and activities recapitulate efforts to assess and approve new drugs, generic drugs, and biologics and strategies for advancing new initiatives.
From the Editor
Bio/pharma works hard today to change the calendar to tomorrow.
Ask The Expert
Auditing distribution suppliers provides understanding and documentation of the services performed.